297 related articles for article (PubMed ID: 33258158)
1. Phenobarbital and midazolam suppress neonatal seizures in a noninvasive rat model of birth asphyxia, whereas bumetanide is ineffective.
Johne M; Römermann K; Hampel P; Gailus B; Theilmann W; Ala-Kurikka T; Kaila K; Löscher W
Epilepsia; 2021 Apr; 62(4):920-934. PubMed ID: 33258158
[TBL] [Abstract][Full Text] [Related]
2. Bumetanide potentiates the anti-seizure and disease-modifying effects of midazolam in a noninvasive rat model of term birth asphyxia.
Welzel B; Johne M; Löscher W
Epilepsy Behav; 2023 May; 142():109189. PubMed ID: 37037061
[TBL] [Abstract][Full Text] [Related]
3. A combination of phenobarbital and the bumetanide derivative bumepamine prevents neonatal seizures and subsequent hippocampal neurodegeneration in a rat model of birth asphyxia.
Johne M; Käufer C; Römermann K; Gailus B; Gericke B; Löscher W
Epilepsia; 2021 Jun; 62(6):1460-1471. PubMed ID: 33955541
[TBL] [Abstract][Full Text] [Related]
4. The loop diuretic torasemide but not azosemide potentiates the anti-seizure and disease-modifying effects of midazolam in a rat model of birth asphyxia.
Welzel B; Schmidt R; Kirchhoff L; Gramer M; Löscher W
Epilepsy Behav; 2023 Feb; 139():109057. PubMed ID: 36586153
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Randomized, Controlled, Double-Blind Trial of Bumetanide to Treat Neonatal Seizures.
Soul JS; Bergin AM; Stopp C; Hayes B; Singh A; Fortuno CR; O'Reilly D; Krishnamoorthy K; Jensen FE; Rofeberg V; Dong M; Vinks AA; Wypij D; Staley KJ;
Ann Neurol; 2021 Feb; 89(2):327-340. PubMed ID: 33201535
[TBL] [Abstract][Full Text] [Related]
6. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model.
Dzhala VI; Brumback AC; Staley KJ
Ann Neurol; 2008 Feb; 63(2):222-35. PubMed ID: 17918265
[TBL] [Abstract][Full Text] [Related]
7. The bumetanide prodrug BUM5, but not bumetanide, potentiates the antiseizure effect of phenobarbital in adult epileptic mice.
Erker T; Brandt C; Töllner K; Schreppel P; Twele F; Schidlitzki A; Löscher W
Epilepsia; 2016 May; 57(5):698-705. PubMed ID: 26921222
[TBL] [Abstract][Full Text] [Related]
8. Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures.
Cleary RT; Sun H; Huynh T; Manning SM; Li Y; Rotenberg A; Talos DM; Kahle KT; Jackson M; Rakhade SN; Berry G; Jensen FE
PLoS One; 2013; 8(3):e57148. PubMed ID: 23536761
[TBL] [Abstract][Full Text] [Related]
9. Effects of bumetanide on neonatal seizures: A systematic review of animal and human studies.
Rao S; Farhat A; Rakshasbhuvankar A; Athikarisamy S; Ghosh S; Nagarajan L
Seizure; 2023 Oct; 111():206-214. PubMed ID: 37690372
[TBL] [Abstract][Full Text] [Related]
10. Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice.
Hampel P; Römermann K; Gailus B; Johne M; Gericke B; Kaczmarek E; Löscher W
Neuropharmacology; 2021 Mar; 185():108449. PubMed ID: 33450274
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of bumetanide at brain concentrations incompatible with NKCC1 inhibition on newborn DGC structure and spontaneous EEG seizures following hypoxia-induced neonatal seizures.
Wang S; Zhang XQ; Song CG; Xiao T; Zhao M; Zhu G; Zhao CS
Neuroscience; 2015 Feb; 286():203-15. PubMed ID: 25463517
[TBL] [Abstract][Full Text] [Related]
12. Phenobarbital, midazolam, bumetanide, and neonatal seizures: The devil is in the details.
Ben-Ari Y; Delpire E
Epilepsia; 2021 Apr; 62(4):935-940. PubMed ID: 33534145
[TBL] [Abstract][Full Text] [Related]
13. Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy.
Brandt C; Seja P; Töllner K; Römermann K; Hampel P; Kalesse M; Kipper A; Feit PW; Lykke K; Toft-Bertelsen TL; Paavilainen P; Spoljaric I; Puskarjov M; MacAulay N; Kaila K; Löscher W
Neuropharmacology; 2018 Dec; 143():186-204. PubMed ID: 30248303
[TBL] [Abstract][Full Text] [Related]
14. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial.
Pressler RM; Boylan GB; Marlow N; Blennow M; Chiron C; Cross JH; de Vries LS; Hallberg B; Hellström-Westas L; Jullien V; Livingstone V; Mangum B; Murphy B; Murray D; Pons G; Rennie J; Swarte R; Toet MC; Vanhatalo S; Zohar S;
Lancet Neurol; 2015 May; 14(5):469-77. PubMed ID: 25765333
[TBL] [Abstract][Full Text] [Related]
15. Ganaxolone versus Phenobarbital for Neonatal Seizure Management.
Miller SL; Bennet L; Sutherland AE; Pham Y; McDonald C; Castillo-Melendez M; Allison BJ; Mihelakis J; Nitsos I; Boyd BJ; Hirst JJ; Walker DW; Hunt RW; Jenkin G; Wong F; Malhotra A; Fahey MC; Yawno T
Ann Neurol; 2022 Dec; 92(6):1066-1079. PubMed ID: 36054160
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome in a noninvasive rat model of birth asphyxia with neonatal seizures: Cognitive impairment, anxiety, epilepsy, and structural brain alterations.
Gailus B; Naundorf H; Welzel L; Johne M; Römermann K; Kaila K; Löscher W
Epilepsia; 2021 Nov; 62(11):2826-2844. PubMed ID: 34458992
[TBL] [Abstract][Full Text] [Related]
17. Question 1: Phenobarbital for preventing mortality and morbidity in full-term newborns with perinatal asphyxia in a resource-poor setting.
Spiers H; Twesigomwe G; Cartledge P
Arch Dis Child; 2015 Oct; 100(10):1000-3. PubMed ID: 26386130
[No Abstract] [Full Text] [Related]
18. NKCC1 transporter facilitates seizures in the developing brain.
Dzhala VI; Talos DM; Sdrulla DA; Brumback AC; Mathews GC; Benke TA; Delpire E; Jensen FE; Staley KJ
Nat Med; 2005 Nov; 11(11):1205-13. PubMed ID: 16227993
[TBL] [Abstract][Full Text] [Related]
19. Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1.
Kahle KT; Barnett SM; Sassower KC; Staley KJ
J Child Neurol; 2009 May; 24(5):572-6. PubMed ID: 19406757
[TBL] [Abstract][Full Text] [Related]
20. Reply to the commentary by Ben-Ari and Delpire: Bumetanide and neonatal seizures: Fiction versus reality.
Löscher W; Kaila K
Epilepsia; 2021 Apr; 62(4):941-946. PubMed ID: 33764535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
